Market closed

Milestone Pharmaceuticals/MIST

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Ticker

MIST
Trading on

Industry

Pharmaceuticals

Headquarters

Montreal, Canada

Employees

47

MIST Metrics

BasicAdvanced
$99M
Market cap
-
P/E ratio
-$0.96
EPS
1.72
Beta
-
Dividend rate
$99M
1.72
$3.52
$1.12
116K
19.128
18.67
164.76
166.533
-14.26%
-33.09%
-133.75%
3.1
3.1
-2.051
-100.00%
-30.31%
3.74%

What the Analysts think about MIST

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Milestone Pharmaceuticals stock.

MIST Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MIST Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy MIST

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Milestone Pharmaceuticals stock?

Milestone Pharmaceuticals (MIST) has a market cap of $99M as of October 06, 2024.

What is the P/E ratio for Milestone Pharmaceuticals stock?

The price to earnings (P/E) ratio for Milestone Pharmaceuticals (MIST) stock is 0 as of October 06, 2024.

Does Milestone Pharmaceuticals stock pay dividends?

No, Milestone Pharmaceuticals (MIST) stock does not pay dividends to its shareholders as of October 06, 2024.

When is the next Milestone Pharmaceuticals dividend payment date?

Milestone Pharmaceuticals (MIST) stock does not pay dividends to its shareholders.

What is the beta indicator for Milestone Pharmaceuticals?

Milestone Pharmaceuticals (MIST) has a beta rating of 1.72. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.